Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

15.0K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
15.0K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.8K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.4K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.6K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

894
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
894
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic ketamine use associated with progressive multisystem organ dysfunction.

BMJ case reports·2026
Same author

Apparent diffusion coefficient benchmarking and inter-scanner variability; preparing for biological image guided adaptive radiotherapy treatments.

Radiography (London, England : 1995)·2025
Same author

Robotic-assisted versus laparoscopic surgery for colorectal cancer in high-risk patients: a systematic review and meta-analysis.

Techniques in coloproctology·2025
Same author

Open versus robotic-assisted techniques for multivisceral pelvic resections of locally advanced or recurrent colorectal and anal cancers: short-term outcomes from a single centre.

Techniques in coloproctology·2024
Same author

Tremor in triventricular hydrocephalus secondary to an aqueductal web with stenosis and response to third ventricular ventriculostomy.

British journal of neurosurgery·2022
Same author

Quantum limits of position-sensitive photodiodes.

Optics express·2022

Related Experiment Video

Updated: Apr 4, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.1K

Diabetic hepatosclerosis: another diabetes microvascular complication?

R J King1, L Harrison2, S G Gilbey1

  • 1Department of Diabetes and Endocrinology, Leeds Teaching Hospitals NHS Trust, St James' University Hospital, Leeds, UK.

Diabetic Medicine : a Journal of the British Diabetic Association
|August 29, 2015
PubMed
Summary

Diabetic hepatosclerosis, a liver condition in diabetes without fat, shows slow progression over 11 years in a case study. Long-term follow-up is crucial for understanding its impact on liver disease progression.

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.5K

Related Experiment Videos

Last Updated: Apr 4, 2026

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
06:26

Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis

Published on: July 18, 2025

1.1K
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.2K
An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
10:17

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes

Published on: April 26, 2019

7.5K

Area of Science:

  • Hepatology
  • Diabetology
  • Microvascular Complications

Background:

  • Liver disease is common in diabetes, often due to hepatic steatosis.
  • Diabetic hepatosclerosis is a distinct condition characterized by sinusoidal fibrosis without steatosis in diabetic patients with cholestasis.
  • It is considered a manifestation of hepatic diabetic microangiopathy, linked to other microvascular issues.

Observation:

  • A 50-year-old woman with Type 1 diabetes and multiple complications presented with cholestasis and abnormal liver function tests.
  • Liver biopsy revealed sinusoidal fibrosis without steatosis, confirming diabetic hepatosclerosis.
  • Previous biopsy 11 years prior showed slow progression of sinusoidal fibrosis.

Findings:

  • This case represents the longest documented clinical course of diabetic hepatosclerosis (11 years).
  • The patient did not develop cirrhosis or portal hypertension during the observation period.
  • The clinical relevance and long-term effects of diabetic hepatosclerosis remain poorly understood due to limited data.

Implications:

  • Further research is needed to understand the clinical course, morbidity, and mortality associated with diabetic hepatosclerosis.
  • Patients diagnosed with this condition require long-term, low-intensity follow-up to better elucidate its sequelae.
  • This case highlights the importance of recognizing diabetic hepatosclerosis as a potential complication in diabetic patients with liver dysfunction.